COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
AllRock Bio is a clinical-stage biotech developing ROC-101, a first-in-class oral pan-ROCK inhibitor for pulmonary arterial hypertension (PAH) and ILD-PH.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
